Target intelligence / Profile preview

L-Alanine (Ala)

Target
Ala
Molecular classification
Amino acid, Metabolite, Other
01

Overview

L-Alanine is a non-essential alpha-amino acid that serves as a fundamental building block for protein synthesis in all living organisms (PubChem CID 5950). It plays a pivotal role in the glucose-alanine cycle, a metabolic pathway where alanine is transported from muscle to the liver to be converted into glucose via gluconeogenesis (StatPearls NBK542205). This process is essential for maintaining blood glucose levels during fasting and exercise. While alanine itself is not a traditional therapeutic target for drug intervention, its metabolic enzymes, such as alanine aminotransferase (ALT), are critical clinical biomarkers for liver health and systemic metabolic function (NIH/MedlinePlus). In a pharmacological context, alanine is primarily utilized as a component of parenteral nutrition and dietary supplements rather than as a site for small molecule or biologic binding (DrugBank DB00155). Imbalances in alanine metabolism are associated with various conditions, including hyperalaninemia and certain urea cycle disorders (OMIM 603580).

Other names
(S)-2-aminopropanoic acidL-alpha-alanine2-Aminopropionic acidL-Ala
02

Mechanism of action

L-Alanine is not a therapeutic target; it serves as a fundamental substrate for protein synthesis and a key intermediate in the glucose-alanine cycle for gluconeogenesis (StatPearls NBK542205).

03

Biological functions

Protein biosynthesisGluconeogenesisNitrogen metabolismGlucose-alanine cycleOther
04

Disease associations

Liver diseaseHyperalaninemiaDiabetesUrea cycle disordersOther
05

Safety considerations

Metabolic imbalance in patients with urea cycle disorders (OMIM 603580)Potential for metabolic acidosis with excessive parenteral administration (DrugBank DB00155)
06

Interacting drugs

Parenteral nutrition solutions

2 more in the full profile.

07

Biomarkers

Alanine aminotransferase (ALT)Serum L-alanine concentration

Beyond the preview

Go deeper on L-Alanine (Ala).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-Alanine (Ala).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call